Skip to content
The GLP-1 Verdict
Menu
Ranked #14 · Grade B+

Effecty review

A LegitScript-verified nationwide operator that pairs fair compounded pricing with real brand-name access.

Visit Effecty Assume we may earn a commission, at no cost to you. It never changes The Verdict Score, nor a word of this review.
Semaglutide
$160/mo
Tirzepatide
$240/mo
Coverage
All 50 states
Brand-name
Yes

The scorecard

Effecty scored on our six published factors. See the methodology.

Real-world results86/100
Price honesty87/100
Prescriber access90/100
Formulary choice87/100
Cancellation fairness86/100
Member support86/100

What we like

  • LegitScript-certified and available in all 50 states
  • Brand-name access alongside both compounded molecules
  • Sensible mid-market pricing on both

The caveats

  • No oral route
  • Pricing sits above the aggressive value tier

The verdict

Best for: Patients who want a verified provider that can pivot to brand-name if compounded supply tightens. A LegitScript-verified nationwide operator that pairs fair compounded pricing with real brand-name access.

Ranked #14 of 510 providers we have reviewed — for comparison, read our ruling on CoreAge Rx, our #1 pick. In the ranking it sits between Telos Rx, 85/100 above and Curex at 87/100 below, with the Ro ruling the next one down.

Weighing it against something else? Every provider we would put in front of Effecty is ranked on price honesty, prescriber access and cancellation terms. We have also ruled on it directly: CoreAge Rx vs Effecty goes to CoreAge Rx, 94/100 to 87/100.

Compare with other providers

All 509 other providers we've reviewed, in our overall ranking order.

Every other program we track (503)

Pricing, states and verification reflect Effecty's public disclosures at last review; the Verdict Score is our editorial judgment per the methodology. Prices change — confirm on Effecty's site. Not medical advice; see our disclosure.

← Back to all rankings